These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23497349)

  • 1. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.
    Habermehl D; Debus J; Ganten T; Ganten MK; Bauer J; Brecht IC; Brons S; Haberer T; Haertig M; Jäkel O; Parodi K; Welzel T; Combs SE
    Radiat Oncol; 2013 Mar; 8():59. PubMed ID: 23497349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.
    Combs SE; Habermehl D; Ganten T; Schmidt J; Edler L; Burkholder I; Jäkel O; Haberer T; Debus J
    BMC Cancer; 2011 Feb; 11():67. PubMed ID: 21314962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma.
    Shiba S; Abe T; Shibuya K; Katoh H; Koyama Y; Shimada H; Kakizaki S; Shirabe K; Kuwano H; Ohno T; Nakano T
    BMC Cancer; 2017 Nov; 17(1):721. PubMed ID: 29115938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma.
    Shiba S; Shibuya K; Okamoto M; Okazaki S; Komatsu S; Kubota Y; Nakano T; Ohno T
    Radiat Oncol; 2020 Aug; 15(1):195. PubMed ID: 32795340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger.
    Shibuya K; Ohno T; Katoh H; Okamoto M; Shiba S; Koyama Y; Kakizaki S; Shirabe K; Nakano T
    Radiother Oncol; 2019 Mar; 132():230-235. PubMed ID: 30366726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials.
    Kasuya G; Kato H; Yasuda S; Tsuji H; Yamada S; Haruyama Y; Kobashi G; Ebner DK; Okada NN; Makishima H; Miyazaki M; Kamada T; Tsujii H;
    Cancer; 2017 Oct; 123(20):3955-3965. PubMed ID: 28662297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
    Hoegen-Saßmannshausen P; Naumann P; Hoffmeister-Wittmann P; Ben Harrabi S; Seidensaal K; Weykamp F; Mielke T; Ellerbrock M; Habermehl D; Springfeld C; Dill MT; Longerich T; Schirmacher P; Mehrabi A; Chang DH; Hörner-Rieber J; Jäkel O; Haberer T; Combs SE; Debus J; Herfarth K; Liermann J
    JHEP Rep; 2024 Jun; 6(6):101063. PubMed ID: 38737600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study.
    Shibuya K; Ohno T; Terashima K; Toyama S; Yasuda S; Tsuji H; Okimoto T; Shioyama Y; Nemoto K; Kamada T; Nakano T;
    Liver Int; 2018 Dec; 38(12):2239-2247. PubMed ID: 30240527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
    Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
    Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines.
    Habermehl D; Ilicic K; Dehne S; Rieken S; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
    PLoS One; 2014; 9(12):e113591. PubMed ID: 25460352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long-term outcomes from a phase I trial.
    Hong Z; Zhang W; Cai X; Yu Z; Sun J; Wang W; Lin L; Zhao J; Cheng J; Zhang G; Zhang Q; Jiang G; Wang Z
    Cancer Sci; 2023 Mar; 114(3):976-983. PubMed ID: 36310409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
    Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.
    Combs SE; Habermehl D; Kieser M; Dreher C; Werner J; Haselmann R; Jäkel O; Jäger D; Büchler MW; Debus J
    BMC Cancer; 2013 Sep; 13():419. PubMed ID: 24034562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
    Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
    Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
    Habl G; Uhl M; Katayama S; Kessel KA; Hatiboglu G; Hadaschik B; Edler L; Tichy D; Ellerbrock M; Haberer T; Wolf MB; Schlemmer HP; Debus J; Herfarth K
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):435-443. PubMed ID: 27084659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Tomizawa K; Shibuya K; Shiba S; Okazaki S; Miyasaka Y; Oishi M; Okamoto M; Ohno T
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1100-1109. PubMed ID: 36870514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma.
    Hayashi K; Suzuki O; Wakisaka Y; Ichise K; Uchida H; Anzai M; Hasegawa A; Seo Y; Shimizu S; Ishii T; Teshima T; Fujimoto J; Ogawa K
    Radiat Oncol; 2024 Apr; 19(1):51. PubMed ID: 38649902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
    Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.